246 related articles for article (PubMed ID: 25885121)
21. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia.
Pullarkat V; Aldoss I
Crit Rev Oncol Hematol; 2015 Jul; 95(1):38-45. PubMed ID: 25624175
[TBL] [Abstract][Full Text] [Related]
23. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis and acute myeloid leukemia.
Haouas H
Hematology; 2014 Sep; 19(6):311-23. PubMed ID: 24192539
[TBL] [Abstract][Full Text] [Related]
25. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia a prospective study.
Kushwaha R; Kumar A; Aggrawal K; Nigam N; Kumar A
Indian J Pathol Microbiol; 2014; 57(1):72-7. PubMed ID: 24739836
[TBL] [Abstract][Full Text] [Related]
26. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
[TBL] [Abstract][Full Text] [Related]
27. CD34 immunohistochemistry in bone marrow biopsies for early response assessment in acute myeloid leukemia.
Jain S; Mahapatra M; Pati HP
Int J Lab Hematol; 2015 Dec; 37(6):746-51. PubMed ID: 26248894
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
29. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
Kumar S; Gertz MA; Dispenzieri A; Lacy MQ; Wellik LA; Fonseca R; Lust JA; Witzig TE; Kyle RA; Greipp PR; Rajkumar SV
Bone Marrow Transplant; 2004 Aug; 34(3):235-9. PubMed ID: 15170170
[TBL] [Abstract][Full Text] [Related]
31. A morphometric study of bone marrow angiogenesis in hairy cell leukaemia with clinicopathological correlations.
Korkolopoulou P; Gribabis DA; Kavantzas N; Angelopoulou MK; Siakantaris MP; Patsouris E; Androulaki A; Thymara I; Kokoris SI; Kyrtsonis MC; Kittas C; Pangalis GA
Br J Haematol; 2003 Sep; 122(6):900-10. PubMed ID: 12956759
[TBL] [Abstract][Full Text] [Related]
32. Clinical correlation of bone marrow microvessel density in essential thrombocythemia.
Panteli K; Zagorianakou N; Agnantis NJ; Bourantas KL; Bai M
Acta Haematol; 2005; 114(2):99-103. PubMed ID: 16103633
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival.
Kuzu I; Beksac M; Arat M; Celebi H; Elhan AH; Erekul S
Leuk Lymphoma; 2004 Jun; 45(6):1185-90. PubMed ID: 15359999
[TBL] [Abstract][Full Text] [Related]
34. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
35. Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.
Carrai V; Miniati I; Guiducci S; Capaccioli G; Alterini R; Saccardi R; Conforti ML; Rigacci L; Rotunno G; Bosi A; Cerinic MM
Rheumatology (Oxford); 2012 Jun; 51(6):1042-8. PubMed ID: 22271757
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of vascular density and fibrosis in the bone marrow of children with high-risk acute lymphoblastic leukemia.
Norén-Nyström U; Roos G; Bergh A; Forestier E
Leukemia; 2005 Nov; 19(11):1998-2001. PubMed ID: 16179911
[No Abstract] [Full Text] [Related]
37. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.
Sucak GT; Aki SZ; Yüzbaşioğlu B; Akyürek N; Yağci M; Bağriaçik U; Haznedar R
Leuk Lymphoma; 2011 Jul; 52(7):1281-9. PubMed ID: 21599578
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis in the bone marrow of patients with breast cancer.
Chavez-Macgregor M; Aviles-Salas A; Green D; Fuentes-Alburo A; Gómez-Ruiz C; Aguayo A
Clin Cancer Res; 2005 Aug; 11(15):5396-400. PubMed ID: 16061853
[TBL] [Abstract][Full Text] [Related]
40. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.
Padró T; Ruiz S; Bieker R; Bürger H; Steins M; Kienast J; Büchner T; Berdel WE; Mesters RM
Blood; 2000 Apr; 95(8):2637-44. PubMed ID: 10753845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
